A phase IIa trial to assess the safety and efficacy of BL-8040 and pembrolizumab in patients with metastatic pancreatic adenocarcinoma (PDAC)Manuel Hidalgo, Daniel D. Von Hoff, Brian M. Wolpin et al.|Annals of Oncology|2018Cited by 4